Company news
Nuvo Pharmaceuticals Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Nuvo Pharmaceuticals(TM) Provides VIMOVO Patent Update
July 30, 2019
Nuvo Pharmaceuticals(TM) Provides Corporate Update
June 17, 2019
Nuvo Pharmaceuticals(TM) Announces that U.S. Court of Appeals for the Federal Circuit Reverses District Court's Decision Related to Certain Vimovo Patents
May 15, 2019
Nuvo Pharmaceuticals(TM) Announces 2019 First Quarter Results
May 14, 2019
Nuvo Pharmaceuticals(TM) to Present at the Bloom Burton & Co. Healthcare Investor Conference
April 23, 2019
Nuvo Pharmaceuticals(TM) Announces Pennsaid 2% Marketing Authorization Application Accepted for Review by AGES, the Austrian Agency for Health and Food Safety
April 2, 2019
Nuvo Pharmaceuticals(TM) Announces 2018 Fourth Quarter and Year-End Results
March 29, 2019
Nuvo Pharmaceuticals(TM) Announces the Filing of the Business Acquisition Report Related to the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets
March 15, 2019
Nuvo Pharmaceuticals(TM) Announces Receipt of Shareholder Approval By Way of Written Consent For the Issuance of Common Shares Pursuant to Convertible Notes and Warrants
March 11, 2019
Nuvo Pharmaceuticals(TM) Announces Appointment of Rob Harris as Executive Chairman
January 3, 2019
Nuvo Pharmaceuticals(TM) to Host Conference Call/Audio Webcast to Discuss the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets
January 2, 2019
Nuvo Pharmaceuticals(TM) Announces Completion of the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets
December 31, 2018
Nuvo Pharmaceuticals(TM) (Ireland) DAC Enters into Resultz® License and Supply Agreement with Heumann Pharma GmbH & Co. Generica KG for Germany
December 21, 2018
Nuvo Pharmaceuticals(TM) Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
November 29, 2018
Nuvo Pharmaceuticals(TM) Announces 2018 Third Quarter Results
November 8, 2018
Nuvo Pharmaceuticals(TM) Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
September 19, 2018
Nuvo Pharmaceuticals(TM) Announces Extension of Exclusivity Period with Aralez and Deerfield
August 20, 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
August 10, 2018
Nuvo Pharmaceuticals(TM) Announces 2018 Second Quarter Results
August 2, 2018
Nuvo Pharmaceuticals(TM)(Ireland) Limited Enters into Resultz® License and Supply Agreement with Fagron Belgium NV for Belgium, the Netherlands and Luxembourg
July 23, 2018
Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting
May 10, 2018
Nuvo Pharmaceuticals(TM) Announces 2018 First Quarter Results
May 10, 2018
Nuvo Pharmaceuticals Inc. Presentation Now Available for On-Demand Viewing
April 16, 2018
Nuvo Pharmaceuticals Inc. to Webcast, Live, at VirtualInvestorConferences.com April 11, 2018
April 9, 2018
Nuvo Pharmaceuticals(TM) Announces 2017 Fourth Quarter and Year-End Results
March 23, 2018
Nuvo Pharmaceuticals (Ireland) Limited Acquires U.S. Product Rights to Resultz® from Piedmont Pharmaceuticals LLC
January 15, 2018
Nuvo Pharmaceuticals Inc.(TM) Acquires Global ex-U.S. Product Rights and existing Royalty Streams to Resultz® from Piedmont Pharmaceuticals LLC
January 2, 2018
Nuvo Pharmaceuticals(TM) Enters into Pennsaid® 2% License Agreement with Gebro Pharma AG for Switzerland and Liechtenstein
December 14, 2017
Nuvo Pharmaceuticals(TM) Announces Normal Course Issuer Bid
November 30, 2017
Nuvo Pharmaceuticals(TM) Commences Trading on the OTCQX® Market in the U.S.
November 28, 2017
Nuvo Pharmaceuticals(TM) Announces Appointment of Jesse Ledger as President & Chief Executive Officer
November 22, 2017
Nuvo Pharmaceuticals(TM) Announces 2017 Third Quarter Results
November 1, 2017
Nuvo Pharmaceuticals(TM) Secures Credit Facility from the Royal Bank of Canada
August 24, 2017
Nuvo Pharmaceuticals(TM) Announces 2017 Second Quarter Results
August 9, 2017
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid® 2%
May 15, 2017
Nuvo Pharmaceuticals(TM) Announces District Court Decision to Uphold U.S. Pennsaid® 2% Patent
May 15, 2017
Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting
May 11, 2017
Nuvo Pharmaceuticals(TM) Announces 2017 First Quarter Results
May 10, 2017
Nuvo Pharmaceuticals(TM) Enters into Pennsaid® 2% License Agreement with Sayre Therapeutics PVT Ltd. for India, Sri Lanka, Bangladesh and Nepal
March 28, 2017
Nuvo Pharmaceuticals(TM) Announces 2016 Year-End and Fourth Quarter Results
March 1, 2017
Nuvo Pharmaceuticals(TM) Inc. Appoints Jesse Ledger as President
November 16, 2016
Nuvo Pharmaceuticals(TM) Announces 2016 Third Quarter Results
November 10, 2016
Nuvo Pharmaceuticals(TM) Receives Approval from German Regulatory Authorities to Conduct Pennsaid® 2% Phase 3 Trial for Treatment of Acute Ankle Sprains
October 17, 2016
Nuvo Pharmaceuticals(TM) Inc. Appoints New Chief Financial Officer
September 1, 2016
Nuvo Pharmaceuticals(TM) Announces 2016 Second Quarter Results
August 10, 2016
Nuvo Pharmaceuticals(TM) Inc. Announces Pennsaid 2% Phase 3 Trial to Support Regulatory Approvals in the E.U., Canada and Australia
July 13, 2016
Nuvo Pharmaceuticals, Anti-Inflammatory Medicine with Less Side Effects, CEO Clip Video
June 24, 2016
Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting
June 7, 2016
Nuvo Pharmaceuticals(TM) Announces 2016 First Quarter Results
May 11, 2016
Nuvo Pharmaceuticals(TM) Inc. announces appointment of Vice President, Business Development
April 4, 2016